Natural History of Grade 1 Cervical Intraepithelial Neoplasia in Women With Human Immunodeficiency Virus
Authors:
- L Stewart MassadLML Stewart Massad
- Charlesnika T. EvansCECharlesnika T. Evans
- Howard MinkoffHMHoward Minkoff
- D Heather WattsDWD Heather Watts
- Howard D. StricklerHSHoward D. Strickler
- Teresa DarraghTDTeresa Darragh
- Alexandra LevineALAlexandra Levine
- Kathryn AnastosKAKathryn Anastos
- Michael MoxleyMMMichael Moxley
- Douglas J. PassaroDPDouglas J. Passaro
- 1 November 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 104 (5, Part 1) , 1077-1085
Abstract
We sought to estimate rates of progression and regression of grade 1 cervical intraepithelial neoplasia (CIN 1) among women with human immunodeficiency virus (HIV). In a multicenter prospective cohort study, HIV-seropositive and HIV-seronegative women were evaluated colposcopically after receiving an abnormal cytology test result between November 1994 and September 2002. Women with CIN 1 were included, except those who had undergone hysterectomy, cervical therapy, or had CIN 2-3 or cervical cancer. Those women who were included were followed cytologically twice yearly, with colposcopy repeated for atypia or worse. We followed 223 women with CIN 1 (202 HIV seropositive and 21 HIV seronegative) for a mean of 3.3 person-years. Progression occurred in 8 HIV-seropositive women (incidence density, 1.2/100 person-years; 95% confidence interval [CI] 0.5-2.4/100 person-years) and in no HIV seronegative women. Regression occurred in 66 (33%) HIV-seropositive women (13/100 person-years, 95% CI 10-16/100 person-years) versus 14 (67%) seronegative women (32/100 person-years, relative risk 0.40, 95% CI 0.25-0.66; P < .001). In multivariate analysis, regression was associated with human papillomavirus (HPV) detection (hazard ratio [HR] for low risk 0.28, 95% CI 0.13-0.61, P = .001; and for high-risk 0.34, 95% CI 0.20-0.55, P < .001 versus no HPV detected) and Hispanic ethnicity (HR 0.48, 95% CI 0.230.98; P = .04); HIV serostatus was only marginally linked to regression (HR 0.52, 95% CI 0.27-1.03; P = .06), but seropositive women were less likely to regress when analysis was limited to 146 women with HPV detected at CIN 1 diagnosis (HR 0.18, 95% CI 0.05-0.62; P = .006). Grade 1 cervical intraepithelial neoplasia infrequently progresses in women with HIV. Thus, observation appears safe absent other indications for treatment. II-1.Keywords
This publication has 24 references indexed in Scilit:
- Evolution of Cervical Abnormalities Among Women With HIV-1: Evidence From Surveillance Cytology in the Women's Interagency HIV StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- A longitudinal study of HPV detection and cervical pathology in HIV infected womenSexually Transmitted Infections, 2000
- Cervicovaginal Human Papillomavirus Infection in Human Immunodeficiency Virus-1 (HIV)-Positive and High-Risk HIV-Negative WomenJNCI: Journal of the National Cancer Institute, 1999
- A longitudinal study of human papillomavirus carriage in human immunodeficiency virus–infected and human immunodeficiency virus–uninfected womenAmerican Journal of Obstetrics and Gynecology, 1998
- Prevalence, Risk Factors, and Accuracy of Cytologic Screening for Cervical Intraepithelial Neoplasia in Women with the Human Immunodeficiency VirusGynecologic Oncology, 1998
- Human Papillomavirus Infection in Women Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1997
- Multiple Recurrences of Cervical Intraepithelial Neoplasia in Women With the Human Immunodeficiency VirusObstetrics & Gynecology, 1996
- Cervical Intraepithelial Neoplasia in Women Infected with the Human Immunodeficiency Virus: Outcome after Loop Electrosurgical ExcisionGynecologic Oncology, 1994
- HPV, HIV Infection, and Risk of Cervical Intraepithelial Neoplasia in Former Intravenous Drug AbusersGynecologic Oncology, 1993
- Natural History of Cervical Intraepithelial NeoplasiaInternational Journal of Gynecological Pathology, 1993